PubMed Health⌕ Search

Biomedical subjects

Raja Banerjee

Publications and source records attributed to Raja Banerjee.

5 recordsLinked to original sources
PubMed2006

Association of antitumor antibiotics, mithramycin and chromomycin, with Zn(II).

Chromomycin A(3) (CHR) and mithramycin (MTR), members of the aureolic acid anticancer antibiotics, supposedly act by inhibiting transcription via reversible association with DNA. The complex(es) with bivalent cation such as Mg(2+) and Zn(2+) is (are) the DNA-binding ligand(s). In this paper, we report a detailed study of the association of these antibiotics with the biologically important bivalent cation, Zn(2+), because the zinc chelating ability of the antibiotics has therapeutic potential in the treatment of diseases relating to zinc dyshomeostasis. Spectroscopic methods such as absorbance, fluorescence, and circular dichroism and NMR spectroscopy have been used to characterize and understand the mechanism of complex formation. Our data show that both antibiotics form a single complex with Zn(2+) in the mole ratio of 2:1 in terms of antibiotic:Zn(2+) with an apparent binding affinity in the micro molar range. The complex has been characterized as [(D)(2)Zn(2+)] (where 'D' stands for the antibiotic). The kinetics study of the complex formation between the antibiotic(s) and Zn(2+) suggests the following mechanism: [reaction: see text] Isothermal calorimetric titration has shown that the association is entropy driven, implying the role of water molecules in complex formation. (1)H NMR spectroscopic data of the complex favor a tetrahedral arrangement around the Zn(2+) ion with the antibiotic acting as a bidentate ligand.

Antibiotics, Antineoplastic↗
PubMed2002

Direct evidence for alteration of unfolding profile of a helical peptide by far-ultraviolet circular dichroism aromatic side-chain contribution.

Aromatic side-chains are known to contribute to the far-UV circular dichroism (CD) spectra of peptides and proteins. Among other things, this can significantly affect the measured helix propensities of amino acids [Chakrabartty et al., Biochemistry 32 (1993) 5560-5565]. In order to address how interfering side-chain contributions can affect the backbone unfolding transition of a helical peptide, as monitored by [theta;](222) (molar ellipticity at 222 nm), we have studied the unfolding transition of a short designed (alpha-amino isobutyric acid/alanine-based) helical peptide containing an interacting Tyr residue. The guanidinium hydrochloride-induced unfolding of the peptide, as monitored by [theta;](222), showed the presence of a sharp transition superposed over a much broader transition. When the same experiment was performed with a similar peptide that lacked the interacting Tyr residue, the sharp transition disappeared and only the broad transition remained. The sharp transition was assigned to originate from the interacting Tyr side-chain. This demonstrates that conformationally restricted aromatic side-chains that interact with the helical backbone not only can alter the backbone far-UV CD signal, they may also alter the unfolding profiles, monitored by far-UV CD, rendering them unfit for a simple analysis for extracting the appropriate unfolding thermodynamic parameters.

Circular Dichroism↗
PubMed2002

Effect of phosphorylation on the structure and fold of transactivation domain of p53.

Several phosphorylations are known to occur in the N-terminal transactivation domain of human p53. To explore the structural effects of these phosphorylations, we have chemically synthesized the unphosphorylated p53-(1-39) and its three phosphorylated analogs, phosphorylated at Ser-15, Thr-18, and Ser-20. p53-(1-39) and its Ser-15 and Thr-18 phosphorylated analogs were tested for interaction with p300. The order of binding affinities was similar to that derived from biochemical experiments with the whole protein, indicating functional integrity of the domain. Differences in chemical shifts and coupling constants indicate significant structural changes upon phosphorylations. The single tryptophan in the unphosphorylated domain has an emission maximum and a Stern-Volmer constant that are characteristics of tryptophans situated in protein interiors. The diffusion constant is monomer-like, with an axial ratio of 1:7.5, indicating a significant degree of compaction. Upon phosphorylations, the emission maximum and diffusion constant change significantly toward values that indicate more open conformations. Binding of the hydrophobic probe bis-1-anilino-8-naphthalenesulfonate to the unphosphorylated and one of the phosphorylated domains is also significantly different, suggesting different conformations. We propose that phosphorylations switch the largely folded transactivation domain to more open conformations that interact with transcription factors such as p300/cAMP- responsive element-binding protein-binding protein, leading to enhancement of gene expression.

Amino Acid Sequence↗
PubMed2002

Aib-based peptide backbone as scaffolds for helical peptide mimics.

Helical peptides that can intervene and disrupt therapeutically important protein-protein interactions are attractive drug targets. In order to develop a general strategy for developing such helical peptide mimics, we have studied the effect of incorporating alpha-amino isobutyric acid (Aib), an amino acid with strong preference for helical backbone, as the sole helix promoter in designed peptides. Specifically, we focus on the hdm2-p53 interaction, which is central to development of many types of cancer. The peptide corresponding to the hdm2 interacting part of p53, helical in bound state but devoid of structure in solution, served as the starting point for peptide design that involved replacement of noninteracting residues by Aib. Incorporation of Aib, while preserving the interacting residues, led to significant increase in helical structure, particularly at the C-terminal region as judged by nuclear magnetic resonance and circular dichroism. The interaction with hdm2 was also found to be enhanced. Most interestingly, trypsin cleavage was found to be retarded by several orders of magnitude. We conclude that incorporation of Aib is a feasible strategy to create peptide helical mimics with enhanced receptor binding and lower protease cleavage rate.

Amino Acid Sequence↗